Clinical Trials Directory

Trials / Unknown

UnknownNCT01281826

Dual-energy CT in Detecting Bone Marrow Edema of Vertebral Compression Fractures

Use of Dual-energy CT in Detecting Bone Marrow Edema of Vertebral Compression Fractures

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
National Cheng-Kung University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to 1. Assess bone marrow edema within the VCF by use of a DE CT virtual noncalcium image compared with MR imaging as standard reference. 2. Evaluate parameters related to the BME of the collapsed vertebral body on DE CT virtual noncalcium images, such as the morphologic signs, visual qualitative detection, and quantitative values.

Detailed description

Patients with multiple compression fractures and in those with chronic fracture, determining which vertebra to treat is frequently difficult. In such patients, the treatment location is commonly determined from findings at imaging, which includes magnetic resonance (MR) imaging, bone scintigraphy, and computed tomography (CT). The bone marrow edema (BME) in acute/subacute VCFs is useful in determining the vertebra that is to be treated. MR imaging provides information on anatomic vertebral collapse and the loss of normal T1 high signal intensity from the marrow space of vertebrae with acute fractures. Loss of normal T1 high signal intensity indicates the presence of BME, which is the important sign for the PVP treatment of VCFs. Dual-energy (DE) CT has been used to create a virtual unenhanced scan by subtracting iodine from contrast agent-enhanced CT examinations.We expect that the same technique can be used to calculate a virtual noncalcium image from an unenhanced image, which makes bone marrow accessible for CT diagnosis.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-01-24
Last updated
2011-02-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01281826. Inclusion in this directory is not an endorsement.